Abacavir and lamivudine combination. - Wikidata - awgldk - TriplyDB

Abacavir and lamivudine combination.

Abacavir and lamivudine combination.

http://www.wikidata.org/entity/Q37636061

about

Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.

P2860

Q38040137-0FACBAD0-B8A8-40A9-8743-EA4610057062

P2860

Abacavir and lamivudine combination.

http://www.wikidata.org/entity/Q37636061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Abacavir and lamivudine combination.

@en

Abacavir and lamivudine combination.

@nl

type

label

Abacavir and lamivudine combination.

@en

Abacavir and lamivudine combination.

@nl

prefLabel

Abacavir and lamivudine combination.

@en

Abacavir and lamivudine combination.

@nl

P1433

Q37636061-88368A24-B7E4-4C2F-BD1C-D5895A21DDF9

P1476

Q37636061-A693468E-7231-494C-9D18-DB8E66C6D311

P2093

Q37636061-238C7C54-E47B-4DE6-981F-533D904F512D

Q37636061-6F94DD23-207E-4A5A-B19F-DDFB02754960

Q37636061-7A013D59-98FE-48AA-9B92-4C950A780EC9

P2860

Q37636061-08EA6D6B-1695-42C4-A92A-55B0F725D41E

Q37636061-0C3DFBF7-0618-44E9-A4C0-C269862412F9

Q37636061-281585C3-9903-467C-BE00-8B9FE4F1E009

Q37636061-38282F4D-F99F-47A4-88A7-383CA06134E6

Q37636061-3B39A6EB-E9DD-41F5-BC64-21FD7E6AD38A

Q37636061-3E2D568D-3B20-476E-A1F6-E3F614763A2E

Q37636061-478BD9E3-8879-48D1-8B4E-90B1BB054FB3

Q37636061-58EB25FE-6851-4B5F-B3E8-18B9BCE2304E

Q37636061-65999AC2-D089-4540-B011-70F71D7AE1D7

Q37636061-79EAD7F5-26F1-4DC1-A469-8FC33779A269

P304

Q37636061-D75617C9-6B31-4D5F-B621-FA5558ABC254

P31

Q37636061-E59951BF-3D6F-44E3-8868-F9D481257C04

P356

Q37636061-B656ED29-9607-451C-B98F-58665D831741

P407

Q37636061-5AEC0826-89B5-4D89-BC61-05B1B39D8896

P433

Q37636061-38725348-1154-4D15-AC1D-E89CB631D82D

P478

Q37636061-785A5D28-AFCF-4670-8D2D-874D81449185

P577

Q37636061-C0067214-45D3-4EF6-B276-2C5BA9FD63B8

P698

Q37636061-2112E3CF-BE74-416B-9A88-8B335EAB2C46

P356

17425250903439720

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Abacavir and lamivudine combination.

@en

P2093

Ana Paula Velez

http://www.w3.org/2001/XMLSchema#string

Charurut Somboonwit

http://www.w3.org/2001/XMLSchema#string

Don Kurtyka

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ count-guided interruption of antiretroviral treatment

HLA-B*5701 screening for hypersensitivity to abacavir.

The abacavir hypersensitivity reaction: a review.

Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative.

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients.

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.

P304

1599-1606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425250903439720

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19929448

http://www.w3.org/2001/XMLSchema#string